US Patent 11471409 Amlodipine formulations
Patent 11471409 was granted and assigned to Azurity Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114714090
Date of Patent
October 18, 2022
0Patent Application Number
170673960
Date Filed
October 9, 2020
0Patent Citations
Patent Primary Examiner
Edits on 28 Oct, 2022
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+227 characters)
US Patent 11471409 Amlodipine formulations
Article
Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114714090
Date of Patent
October 18, 2022
0Patent Application Number
170673960
Date Filed
October 9, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11471409 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
